244 related articles for article (PubMed ID: 8899151)
1. The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human alpha-thrombin.
Keh D; Gerlach M; Kürer I; Seiler S; Kerner T; Falke KJ; Gerlach H
Blood Coagul Fibrinolysis; 1996 Sep; 7(6):615-24. PubMed ID: 8899151
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of platelet glycoprotein IIb/IIIa receptor by nitric oxide donor 3-morpholino-sydnonimine.
Keh D; Thieme A; Kürer I; Falke KJ; Gerlach H
Blood Coagul Fibrinolysis; 2003 Jun; 14(4):327-34. PubMed ID: 12945873
[TBL] [Abstract][Full Text] [Related]
3. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
4. Role of glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) in stimulation of secretion from platelet granules.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2003 Feb; 68(2):209-16. PubMed ID: 12693968
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
Hamilton SF; Miller MW; Thompson CA; Dale GL
J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176
[TBL] [Abstract][Full Text] [Related]
6. Response of neonatal platelets to nitric oxide in vitro.
Keh D; Kürer I; Dudenhausen JW; Woltmann W; Falke KJ; Gerlach H
Intensive Care Med; 2001 Jan; 27(1):283-6. PubMed ID: 11280649
[TBL] [Abstract][Full Text] [Related]
7. P-selectin expression on platelets determines size and stability of platelet aggregates.
Merten M; Thiagarajan P
Circulation; 2000 Oct; 102(16):1931-6. PubMed ID: 11034941
[TBL] [Abstract][Full Text] [Related]
8. Effects of leukocyte-derived cathepsin G on platelet membrane glycoprotein Ib-IX and IIb-IIIa complexes: a comparison with thrombin.
Molino M; Di Lallo M; Martelli N; de Gaetano G; Cerletti C
Blood; 1993 Oct; 82(8):2442-51. PubMed ID: 8400294
[TBL] [Abstract][Full Text] [Related]
9. Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets.
Simák J; Holada K; Janota J; Stranák Z
Pediatr Res; 1999 Oct; 46(4):445-9. PubMed ID: 10509366
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of GP IIb/IIIa receptors during platelet activation: influence on efficacy of receptor blockade.
Matzdorff A; Voss R
Thromb Res; 2006; 117(3):307-14. PubMed ID: 15894353
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb-IIIa in a patient with an unusual platelet membrane glycoprotein composition.
Macchi L; Nurden P; Marit G; Bihour C; Clofent-Sanchez G; Combrié R; Nurden AT
Am J Hematol; 1998 Feb; 57(2):164-75. PubMed ID: 9462551
[TBL] [Abstract][Full Text] [Related]
12. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils.
Taylor ML; Ilton MK; Misso NL; Watkins DN; Hung J; Thompson PJ
Br J Clin Pharmacol; 1998 Aug; 46(2):139-45. PubMed ID: 9723822
[TBL] [Abstract][Full Text] [Related]
13. Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery disease.
Lindemann S; Klingel B; Fisch A; Meyer J; Darius H
Thromb Res; 1999 Jan; 93(2):51-9. PubMed ID: 9950258
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
Schneider DJ; Taatjes DJ; Sobel BE
Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.
Yakushkin VV; Zyuryaev IT; Khaspekova SG; Sirotkina OV; Ruda MY; Mazurov AV
Platelets; 2011; 22(4):243-51. PubMed ID: 21329420
[TBL] [Abstract][Full Text] [Related]
16. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
Pontiggia L; Steiner B; Ulrichts H; Deckmyn H; Forestier M; Beer JH
Thromb Haemost; 2006 Dec; 96(6):774-80. PubMed ID: 17139372
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets.
Goto S; Salomon DR; Ikeda Y; Ruggeri ZM
J Biol Chem; 1995 Oct; 270(40):23352-61. PubMed ID: 7559492
[TBL] [Abstract][Full Text] [Related]
18. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
19. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
[TBL] [Abstract][Full Text] [Related]
20. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells.
May AE; Kälsch T; Massberg S; Herouy Y; Schmidt R; Gawaz M
Circulation; 2002 Oct; 106(16):2111-7. PubMed ID: 12379582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
